PDZK1 and pancreatic neoplasm: Furthermore, we evaluated whether PDZK1 could reverse the malignant phenotype of pancreatic cancer via dephosphorylating PTEN using in vitro and in vivo experiments, in an effort to identify the mechanisms of pancreatic carcinogenesis.